Sophia Genetics (SOPH) - מזומן למניה

Stable software licensing revenue driven by a clinical case database reduces the debt load, as confirmed by the cash per share chart, where the indicator value is 1.09. Capital optimization is based on the high-margin SaaS scale of cloud algorithms and the impeccable global prestige of SOPHiA GENETICS SA (SOPH) in the field of genomic analysis, ensuring the full trust of medical institutions.
פילוחים אנליטיים של חברת SOPHiA GENETICS SA

This metric determines the volume of highly liquid assets per security, allowing for an assessment of the real financial strength and intrinsic value of the company. For SOPHiA GENETICS SA (SOPH), this safety cushion is critical when overcoming GDPR regulatory barriers and integrating AI into medicine; therefore, the trend of liquid assets per share confirms the business's ability to sustain expansion without risking operational stability.